Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Evolus (EOLS) EBIT (2018 - 2025)

Evolus' EBIT history spans 8 years, with the latest figure at $4.2 million for Q4 2025.

  • For Q4 2025, EBIT rose 282.37% year-over-year to $4.2 million; the TTM value through Dec 2025 reached -$32.7 million, up 5.08%, while the annual FY2025 figure was -$32.7 million, 5.08% up from the prior year.
  • EBIT reached $4.2 million in Q4 2025 per EOLS's latest filing, up from -$11.5 million in the prior quarter.
  • In the past five years, EBIT ranged from a high of $8.0 million in Q1 2021 to a low of -$21.3 million in Q2 2022.
  • Average EBIT over 5 years is -$11.3 million, with a median of -$12.7 million recorded in 2023.
  • Peak YoY movement for EBIT: plummeted 292.47% in 2022, then soared 282.37% in 2025.
  • A 5-year view of EBIT shows it stood at -$18.0 million in 2021, then surged by 41.0% to -$10.6 million in 2022, then increased by 18.82% to -$8.6 million in 2023, then surged by 73.2% to -$2.3 million in 2024, then skyrocketed by 282.37% to $4.2 million in 2025.
  • Per Business Quant, the three most recent readings for EOLS's EBIT are $4.2 million (Q4 2025), -$11.5 million (Q3 2025), and -$10.2 million (Q2 2025).